Literature DB >> 29756081

Favourable Prognosis when Lung-Cancer Patients with Superior Vena Cava Obstruction (SVCO) are Referred Promptly to EBUS-TBNA Prior to Medical or Surgical Management.

Leon G D'Cruz1,2, Bassam Younes1, F Anthony Lai2, Syed Arshad Husain1.   

Abstract

BACKGROUND: Primary care patients with superior vena cava obstruction (SVCO) syndrome are usually referred to emergency departments for urgent medical management (high-dose corticosteroids to reduce inflammation), pre-biopsy radiotherapy and/or stent placements to restore patency to the vessel. Biopsy, diagnosis and staging of the mediastinal mass is often postponed until resolution of SVCO symptoms. However, lung cancers metastasise rapidly and delays can influence the eventual outcome of patients. An additional merit in treating SVCO symptoms post-biopsy is that high-dose corticosteroids and pre-biopsy radiotherapy will degrade the quality of biopsy specimens, complicating diagnosis and subsequent management. AIMS: To determine if direct referrals of SVCO patients from primary care to the respiratory department for Endobronchial ultrasound (EBUS)-transbronchial needle-aspiration (TBNA) resulted in better outcomes.
METHODS: Direct referrals to the respiratory department from primary care physicians were sought. A total of 8 patients with symptoms of SVCO were rapidly diagnosed via EBUS-TBNA and ROSE, radiotherapy and specific chemotherapy was initiated following communication with oncology colleagues. High-dose corticosteroids were administered post-EBUS.
RESULTS: Rapid resolution of symptoms for SVCO were noted, without need for surgical intervention. In particular, one patient with small-cell lung cancer (the most aggressive type of lung cancer) remains well and cancer-free 14 months from diagnosis. DISCUSSION: EBUS-TBNA is a safe modality for biopsy in SVCO as there is no risk of further compression of the vessel. We need a paradigm shift in referral and a guideline of SVCO patients in primary care, an urgent biopsy is important in mediastinal cancers which have high metastatic potentials.

Entities:  

Keywords:  EBUS-TBNA; Lung Cancer; Mediastinal Cancer; Prompt Biopsy; ROSE; Small Cell Lung Cancer; Stent; Superior Vena Cava Obstruction (SVCO) Syndrome

Year:  2015        PMID: 29756081      PMCID: PMC5942542     

Source DB:  PubMed          Journal:  Jacobs J Pulmonol        ISSN: 2469-3170


  11 in total

Review 1.  Superior vena cava syndrome--a proposed classification system and algorithm for management.

Authors:  James B Yu; Lynn D Wilson; Frank C Detterbeck
Journal:  J Thorac Oncol       Date:  2008-08       Impact factor: 15.609

2.  Declaration of Helsinki. Ethical principles for medical research involving human subjects.

Authors: 
Journal:  J Indian Med Assoc       Date:  2009-06

3.  The effects of prebiopsy corticosteroid treatment on the diagnosis of mediastinal lymphoma.

Authors:  S H Borenstein; T Gerstle; D Malkin; P Thorner; R M Filler
Journal:  J Pediatr Surg       Date:  2000-06       Impact factor: 2.545

4.  Superior vena cava resection for lung and mediastinal malignancies: a single-center experience with 70 cases.

Authors:  Lorenzo Spaggiari; Francesco Leo; Giulia Veronesi; Piergiorgio Solli; Domenico Galetta; Brunilda Tatani; Francesco Petrella; Davide Radice
Journal:  Ann Thorac Surg       Date:  2007-01       Impact factor: 4.330

Review 5.  Safety and effectiveness of vascular endoprosthesis for malignant superior vena cava syndrome.

Authors:  N P Nguyen; T L Borok; J Welsh; V Vinh-Hung
Journal:  Thorax       Date:  2009-02       Impact factor: 9.139

6.  [Stenting for superior vena cava obstruction associated with lung cancer: monocentric study].

Authors:  M-C Pierre; V Chabbert; S Lozano; L Bigay-Game; N Lévêque; L Desloques; P Otal; H Rousseau; A Didier; J Mazières
Journal:  Rev Mal Respir       Date:  2009-09       Impact factor: 0.622

7.  Emergency prebiopsy radiation for mediastinal masses: impact on subsequent pathologic diagnosis and outcome.

Authors:  J S Loeffler; K A Leopold; A Recht; H J Weinstein; N J Tarbell
Journal:  J Clin Oncol       Date:  1986-05       Impact factor: 44.544

8.  Mid- and long-term follow-up experience in patients with malignant superior vena cava obstruction.

Authors:  Richie Chiu-Lung Chan; Yiu Che Chan; Stephen Wing-Keung Cheng
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-01-10

9.  Small-cell lung cancer in England: trends in survival and chemotherapy using the National Lung Cancer Audit.

Authors:  Aamir Khakwani; Anna L Rich; Laila J Tata; Helen A Powell; Rosamund A Stanley; David R Baldwin; Richard B Hubbard
Journal:  PLoS One       Date:  2014-02-21       Impact factor: 3.240

10.  Ultrasound detection of superior vena cava thrombus.

Authors:  Aaron Birch; David Um; Brooks Laselle
Journal:  West J Emerg Med       Date:  2014-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.